The largest database of trusted experimental protocols

295 protocols using zombie aqua fixable viability kit

1

Flow Cytometric Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood samples were collected from patients after sepsis was diagnosed. Cells were stained with anti-CD45-Brilliant Violet 570™ (BioLegend), anti-CD3-FITC (BioLegend), and anti-CD56-PE (BioLegend). For MX1 and intracellular cytokine staining, 250uL blood from each sample was resuspended and incubated in RPMI 1640 culture medium containing 3% FBS (Mediatech). The cells were then stimulated with a cell activation cocktail (with Brefeldin A) (eBioscience) for 5 h at 37°C. Cells were stained with Zombie AquaTM fixable viability kit (BioLegend), anti-CD45-Alexa Fluor®700 (BioLegend), anti-CD3-Percp-cy5.5 (BioLegend), and anti-CD56-FITC (BioLegend). After surface staining, fixation, and permeabilization, we used anti-MX1-AF647 (Abcam), and anti-IFN-ɑ (Invitrogen). Brilliant Violet 421-conjugated donkey anti-rabbit IgG was used as the secondary antibody (BioLegend).
For mice NK cells, cells were stained with Zombie AquaTM fixable viability kit (BioLegend), anti-NK 1.1-FITC (BioLegend) and anti-MX1 (Proteintech). Alexa Fluor 647-conjugated donkey anti-rabbit IgG was used as the secondary antibody (BioLegend). Data were collected on the LSRFortessaTM flow cytometer (BD Biosciences) and NovocyteD3000 flow cytometer. Data were further analyzed using FlowJo software.
+ Open protocol
+ Expand
2

Immunophenotyping of Immune Cells from Ear Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were prepared from ear tissues, 1 μl of prepared Zombie Aqua Fixable Viability Kit (anti-BV510, BioLegend, USA) was added and incubated for 15 min at room temperature, and 1 μl of prepared surface antibody [Anti-mouse CD45-APC/cy7, (BioLegend; Cat#: 103116; Clone: 30-F11), Anti-mouse FcεRlα-PE/cy7, (BioLegend; Cat#: 334620; Clone: AER-37 (CRA-1)), Anti-mouse CD117 (Kit)-APC, (BioLegend; Cat#: 161505; Clone: S18020A), and Zombie Aqua™ Fixable Viability Kit, (BioLegend; Cat#: 423101)] was added and incubated for 30 min at 4 °C39 (link). The stained cells were analyzed by FACS LSRFORTESSA (BD, USA), and the data were analyzed by Flowjo software.
+ Open protocol
+ Expand
3

Tumor Immune Cell Isolation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors were cut into pieces and incubated in RPMI-1640 (Nacalai Tesque, Kyoto, Japan) supplemented with 0.2% collagenase (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) and 2 KU/mL DNase I (Sigma-Aldrich, St. Louis, Missouri, USA) for 40 min at 37℃. All material was passed through a 70 µm cell strainer to obtain single cell suspensions. After staining dead cells using the Zombie Aqua Fixable Viability Kit (BioLegend) and blocking Fc receptors with anti-CD16/32 mAb, the cells were stained with mAbs for cell surface antigens.
For intracellular cytokine staining, cells were first stimulated with 10 ng/mL PMA (Sigma-Aldrich) and 1 µM ionomycin (Sigma-Aldrich) in the presence of 10 µg/mL brefeldin A (Sigma-Aldrich) for 4 hours. After staining dead cells using the Zombie Aqua Fixable Viability Kit (BioLegend) and blocking Fcγ receptors with anti-CD16/32 mAb, cells were first stained with mAbs for cell surface antigens. After fixation and permeabilization using Fixation Buffer and Intracellular Staining Perm Wash Buffer (BioLegend) according to the manufacturer’s protocols, cells were then stained with PE-conjugated anti-IL-17A and APC-conjugated anti-IFNγ antibodies. Stained cells were acquired on a CytoFLEX S flow cytometer (Beckman Coulter, Atlanta, Georgia, USA) and analyzed using FlowJo software V.10.6.2 (BD Biosciences).
+ Open protocol
+ Expand
4

Apoptosis and Differentiation Assays of Leukemia Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
K562, MOLM13, and MV4;11 cells were plated at 1 × 105 cell/mL and treated for 7 or 8 days with AS-99, AS-nc or DMSO in triplicates in the same way as described for qRT-PCR studies. For Annexin V apoptosis assay, 1 × 105 cells per sample were collected at the end of the treatment, washed with PBS and stained using the FITC Annexin V Apoptosis Detection Kit I (BD Pharmingen™) according to the manufacturer’s instructions. In addition, 1 × 105 cells per sample were stained with Zombie Aqua™ dye (1:100 dilution) for 15 min using the Zombie Aqua™ Fixable Viability Kit (Zombie Aqua™ Fixable Viability Kit, Biolegend®) at 1:50 dilution and then for 30 min with an anti-CD11B-PE antibody (982606, ICRF44, Biolegend®) or anti-CD11B-Pacific Blue (101224, BD BioLegend) antibody at 1:50 dilution, according to the No-wash Sequential Staining Protocol described by the manufacturer (BioLegend, Zombie Aqua Fixable Viability Kit). Cells were washed twice with 500 µL PBS containing 1% FBS and resuspended in 200 µL PBS with 1% FBS. Flow cytometry experiments were performed on FACSCelesta flow cytometer using BD FACSDiva version 8 and all data were analyzed with FlowJo v.10.6.0 software (Tree Star, Inc.).
+ Open protocol
+ Expand
5

Enoxacin Cytotoxicity Evaluation by MTT and Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with enoxacin in different concentrations. Twenty-four hours after treatment, cells were incubated for 4 hours in culture medium containing the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reagent (0.5 mg/ml; Sigma-Aldrich). After 4 hours, the medium was removed followed by addition of dimethyl sulfoxide to lyse the cells and release the formazan product. After 30 min at 37°C, the absorbance was read at 570 nm. Cell viability was also assessed by flow cytometry. After enoxacin treatment, the supernatant was collected, and cells were treated with trypsin. Cells were centrifuged at 300g for 5 min, resuspended in 200 μl of PBS + 2% FBS, and transferred to a 96-well plate followed by a new centrifugation step. The supernatant was removed, and the cells were resuspended in 25 μl of the fluorescent dye Zombie AquaTM Fixable Viability Kit (BioLegend) diluted 1:1000 in PBS and incubated for 20 min at 4°C. Cells were then washed with 100 μl of PBS + 2% FBS and resuspended in 200 μl of PBS + 2% FBS. Unstained cells were used as a negative control. Cells were counted using the BD FACSVerse flow cytometer (BD Biosciences) and quantified using FlowJo software.
+ Open protocol
+ Expand
6

Fluorescent Staining of Polarized MDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescent staining of polarized MDM was performed in PBA-E buffer (PBS with 0.5% BSA, 2 mM EDTA and 0.1% sodium azide). To determine cell viability, cells were stained using the Zombie AquaTM Fixable Viability Kit (Biolegend, San Diego, CA) for 5 min at RT. Nonspecific antibody binding was blocked using mouse serum (10 min, 4 °C). Cells were stained by fluorochrome-labeled antibodies mixtures (20 min, 4 °C); for details, see SI Appendix. After staining, MDMs were measured using BD LSR FortessaTM cell analyzer (BD Biosciences), and data were analyzed using FlowJo X Software (BD Biosciences).
+ Open protocol
+ Expand
7

Characterization of MDS-L Cell Subpopulations

Check if the same lab product or an alternative is used in the 5 most similar protocols
For characterization of different subpopulations, MDS-L cells were stained in PBS with the Zombie AquaTM Fixable Viability Kit (Biolegend, San Diego, USA) for 20 minutes at room temperature and then incubated with a 9-color antibody (Ab) panel for 30 minutes at 2°C. Flow-cytometric evaluation was performed on a BD LSR Fortessa (Becton Dickinson, Heidelberg, Germany), cell sorting on a BD Aria Fusion (BD). BGN surface expression was assessed by staining with a polyclonal rabbit anti-BGN Ab (Novus Biologicals, Littleton, USA) on ice for 30 minutes followed by incubation with an anti-rabbit Cy5 AffiniPure Fab2 (Jackson Immunoresearch, Cambridgeshire, USA) as secondary Ab for 20 minutes on ice.
+ Open protocol
+ Expand
8

Cell Viability Analysis by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell viability was determined by CellTiter-Glo® Luminescent cell viability assay (Promega, Madison, MI) and Zombie AquaTM fixable viability kit (BioLegend, San Diego, CA) according to manufacturer's instructions. Flow cytometry (LSR Fortessa cell analyzer, BD Biosciences, San Jose, CA) was used to record and analyze the cells stained with Zombie AquaTM dye with a maximum emission of 516 nm.
+ Open protocol
+ Expand
9

Comprehensive Lymphocyte Phenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell solutions were prepared from organs as indicated and resuspended in staining buffer containing 5% FBS in PBS. Splenic and tissue-resident lymphocytes were identified with mAbs against the following antigens, all from BioLegend unless otherwise noted: CD8α (MAR-1), CD4 (RM4-5), CD19 (6D5), B220 (RA3-6B2), NK1.1 (eBiosciences, PK136), Gr1 (eBio, RB6-8C5), CD11b (M1/70), CD45.2 (1D4), CD45.1 (A20), CD44 (BDIM7) CD62L (MEL-14), CD45RB (eBio, C363.16a), CD69 (BD Biosciences, H1.2F3), PD-1 (29F.1A12), CD103 (2E7), Ly-6C (HK1.4), CD122 (5H4), CD49d/VLA-4 (R1-2), CD11a (M17/4), CD43aag (1B11), CD29 (HMβ1-1), CD48 (HM48-1), CD49f/VLA-6 (GoH3), CD31 (390), ICAM-1 (YN1/1.74), VCAM-1 (429), TCRβ, (eBio, H57-597). Live and dead cells were separated using Zombie AquaTM Fixable Viability Kit (BioLegend). Data were acquired on an LSR II SORP (BD) equipped with a Violet (406 nm, 100 mW), Blue (adjustable 488 nm, 80 mW; maximum output 100 mW), Green (532 nm, 150 mW) and Red (642 nm, 40 mW) lasers, then analyzed with FlowJo (TreeStar Technologies).
+ Open protocol
+ Expand
10

Zombie Aqua Viability Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells isolated from leukocyte-enriched fractions were incubated by using a Zombie Aqua TM Fixable Viability Kit (Biolegend, San Diego, CA, USA) at room temperature for 15 min, and then anti-CD16/32 antibody (Abcam, United Kingdom) was added at room temperature for 15 min to block Fc receptors. After staining with a mixture of antibodies (Table 2) at 4°C for 20 min, cells were analysed with flow cytometric analysis (Canto II; BD Biosciences, San Jose, CA, USA) and analyzed with FlowJo software (Tree Star, Ashland, OR, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!